Early research (Phase 1)Study completedNCT01300026What this trial is testingAMG 319 Lymphoid Malignancy FIHWho this might be right forCancerChronic Lymphocytic LeukemiaDiffuse Large Cell Lymphoma+11 more Amgen 28
Testing effectiveness (Phase 2)Study completedNCT00086944What this trial is testingOblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaWho this might be right forRecurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell Lymphoma National Cancer Institute (NCI) 25
Post-approval studies (Phase 4)Study completedNCT01990534What this trial is testingBrentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin LymphomaWho this might be right forHodgkin Lymphoma Millennium Pharmaceuticals, Inc. 60
Early research (Phase 1)Active Not RecruitingNCT05574114What this trial is testingRadiation Therapy Before CAR T Cell Therapy for People With B Cell LymphomaWho this might be right forNon-Hodgkin LymphomaNon-Hodgkin's Lymphoma, RelapsedNon-Hodgkin's Lymphoma Refractory Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT03409432What this trial is testingBrentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell LymphomaWho this might be right forLymphomatoid PapulosisPrimary Cutaneous Anaplastic Large Cell LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma+6 more John Reneau 26
Testing effectiveness (Phase 2)Looking for participantsNCT06768905What this trial is testingIOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCLWho this might be right forNon Hodgkin LymphomaDiffuse Large B Cell Lymphoma University of Texas Southwestern Medical Center 30
Not applicableLooking for participantsNCT06866873What this trial is testingCD-19 CAR-T Cell for Pediatric ALL or LymphomaWho this might be right forLymphoma, B-CellAcute Lymphoblastic Leukemia, Pediatric Hong Kong Children's Hospital 18
Early research (Phase 1)Looking for participantsNCT07283796What this trial is testingAssess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forNHL Haisco Pharmaceutical Group Co., Ltd. 110
Large-scale testing (Phase 3)WithdrawnNCT05431179What this trial is testingZilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell LymphomaWho this might be right forLymphoma, Mantle-CellLymphomaLymphoproliferative Disorders+5 more Oncternal Therapeutics, Inc
Testing effectiveness (Phase 2)Ended earlyNCT00776373What this trial is testingRapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid MalignanciesWho this might be right forALLBurkitt's LymphomaLymphoblastic Leukemia+1 more Abramson Cancer Center at Penn Medicine 4
Early research (Phase 1)UnknownNCT04356846What this trial is testingA Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell LymphomaWho this might be right forNon-Hodgkin LymphomaChronic Lymphocytic Leukemia The First Affiliated Hospital with Nanjing Medical University 74
Testing effectiveness (Phase 2)Study completedNCT00865969What this trial is testingBelinostat in Relapsed or Refractory Peripheral T-Cell LymphomaWho this might be right forPeripheral T-cell Lymphoma Spectrum Pharmaceuticals, Inc 129
Early research (Phase 1)Looking for participantsNCT06445803What this trial is testingCD19/CD22 CAR-T Cells in Adults With R/R ALL or NHLWho this might be right forAcute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed RemissionB-cell Lymphoma Refractory+1 more Rong Tao 48
Testing effectiveness (Phase 2)Ended earlyNCT02624986What this trial is testingIdasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) ParticipantsWho this might be right forNon-Hodgkin's Lymphoma Hoffmann-La Roche 25
Testing effectiveness (Phase 2)Ended earlyNCT04189952What this trial is testingAcalabrutinib in Combination With R-ICE For Relapsed or Refractory LymphomaWho this might be right forDiffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia+1 more University of Miami 2
Testing effectiveness (Phase 2)Study completedNCT02987400What this trial is testingCombination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCLWho this might be right forLymphoma, Large B-Cell, Diffuse Arbeitsgemeinschaft medikamentoese Tumortherapie 22
Testing effectiveness (Phase 2)UnknownNCT00036712What this trial is testingLight-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+9 more Medical College of Wisconsin 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT01849263What this trial is testingIbrutinib in Treating Patients With Relapsed or Refractory Follicular LymphomaWho this might be right forGrade 3a Follicular LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular Lymphoma+2 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT06253663What this trial is testingStudy of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaWho this might be right forRelapsed/Refractory Mantle Cell LymphomaRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Kite, A Gilead Company 25
Testing effectiveness (Phase 2)Study completedNCT06074107What this trial is testingStudy of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma SubjectsWho this might be right forRelapsed or Refractory Diffuse Large B-cell Lymphoma BeBetter Med Inc 128